Research programme : cancer therapeutics - Albert Einstein College of Medicine/Jiangsu Hengrui Medicine
Latest Information Update: 27 Apr 2016
Price : $50
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer